Introduction 3 5
Over decades of biomedical investigations, it was found that one of the most distinctive 3 6 features of cancers is the expression of Tn antigen (Tn), which is an N-acetylgalactosamine 3 7 (GalNAc) attached to protein Ser/Thr residues via an O-linked glycosidic linkage 1 . A variant of 3 8
Tn is STn, which has an addition of sialic acid monosaccharide 1 . Tn establishes its nature as a 3 9 pan-carcinoma antigen by finding of its expression in 10-90% of the solid tumor including lung, 4 0 prostate, breast, colon, pancreas, gastric, stomach, ovary, cervix, bladder 1-3 . In sharp contrast, 4 1 the expression of Tn in adult tissue is rare 4 , making it an attractive target for anti-cancer 4 2 applications. Gal( 13 C 6 ) has all six carbon molecules in galactose labeled with carbon-13 featuring an 1 1 1 increment mass of 6 Da. The use of C1GalT1 and UDP-Gal( 13 C 6 ) successfully converted Tn to 1 1 2
Gal( 13 C 6 )-Tn with a unique mass tag of 371 and yielded a charge +2 Gal( 13 C 6 )-Tn-glycopeptide 1 1 3 at 1152.55 m/z ( Fig. 2A top right panel) , which had an increase of ~6 Da compared to its charge Gal( 13 C 6 )-Tn-glycopeptide had an increase of ~6 Da compared to its Gal-Tn or endogenous Gal-1 1 8
GalNAc counterpart at 761.34 m/z ( Fig. 2A bottom middle panel) . Next, the MS/MS spectra of 1 1 9 site-containing Gal( 13 C 6 )-Tn-glycopeptides were analyzed using HCD-MS2 to identify spectral 1 2 0 feature for improvement of confidence of identification. As an illustration, an MS/MS spectrum 1 2 1 of site-containing Gal( 13 C 6 )-Tn-glycopeptide from analysis of Jurkat cells was shown ( Fig. 2B ).
2 2
A diagnostic oxonium ion generated by HCD fragmentation was observed at 372 m/z for the 1 2 3
Gal( 13 C 6 )-Tn (Fig. 2B) . The presence of the diagnostic oxonium ion at 372 m/z was utilized in peptide-spectrum match (PSM) were assigned to 1,078 unique site-containing Gal( 13 C 6 )-Tn-1 3 5
glycopeptides that contained 1,011 unique peptide sequences ( Fig. 3 and Supplementary Table   1 3 6 1). From the peptide sequence, we mapped 947 Gal( 13 C 6 )-Tn-glycosylation sites from 480 1 3 7 glycoproteins ( Fig. 3 and Supplementary Table 1 ). The diagnostic oxonium ion at 372 m/z was 1 3 8 detected in 96.4% of the assigned MS/MS spectra with an overall intensity being ten-fold lower 1 3 9
than that at 204 m/z ( Fig. 4A and Supplementary Table 1 ). The detection of oxonium ion at 372 1 4 0 m/z in the assigned MS2 spectra supported the presence of Gal( 13 C 6 )-Tn in the identified found an overrepresentation of Pro residues at the +3 and -1 position (Fig. 4B ). Two 1 5 0 glycosylation sites residing close to the protein N-termini were not used in the motif analysis. identified glycoproteins in the secretory pathway and on the cell surface ( Fig. 4C ). Next, the 1 5 5
relative position of the glycosylation sites in protein sequence was plotted and showed that C1GalT1 is a natural enzyme with specificity for extending O-GalNAc to core 1 Gal-GalNAc We mapped 947 Tn-glycosylation sites from almost 500 glycoproteins, a substantially large Some site-containing Tn-glycopeptides may be too long or too short to be detected using EXoO-
Tn with trypsin digestion. Digestion of proteins using proteases with different specificities may 1 8 7
further increase the identification number of glycosylation sites in EXoO-Tn methodology. Also, 1 8 8 the identification of glycopeptides with two or three Gal( 13 C 6 )-Tn compositions suggests many 1 8 9 more glycosylation sites in the peptide sequences supporting an even larger number of Tn- cells in the previous study 21 . Given that Tn is prevalent in cancers and other diseases, EXoO-Tn 1 9 5 is anticipated to have broad translational and clinical utilities. TFA. In the concurrent one-pot enzymatic treatment that was used in all experiments described 2 0 8 below, enzymes including C1GalT1/C1GalT1C1, OpeRATOR, and substrate i.e. UDP-Gal or 2 0 9 UDP-Gal 13 C 6 were added at the same time using the amount as described in the above sequential Tris-HCl buffer (pH7.4) with 50 mM NaCNBH 3 at RT for 30 min with rotation. The resin was Include charge state was 2-6. The fixed first mass was 110 m/z. Dynamic exclusion duration was 2 5 7 45 s. oxidation (M), Gal 13 C 6 (1)HexNAc(1) (S/T), Hex(1)HexNAc(1) (S/T) and HexNAc (S/T) and 2 6 8 static modification: carbamidomethylation (C) and guanidination (K). FDR was set at 1% using 2 6 9
Percolator. Only MS/MS scans with oxonium ion at 204, and two of the other oxonium ions were 2 7 0 kept. Assignments with XCorr score below one were removed. MS/MS spectra were manually 2 7 1 studied and inspected using spectral viewer in Proteome Discoverer to identify the spectral 2 7 2 feature and ensure the confidence of identification. We acknowledge Dr. Kyung-Cho Cho for maintenance of Mass Spectrometer. This work was The authors declare no competing financial interests. Gal( 13 C 6 )-Tn-glycopeptide identified in Jurkat cells. A diagnostic oxonium ion at 372 3 2 9
corresponding to fragmentation ion of Gal( 13 C 6 )-Tn was colored in purple. 
